News

The FDA granted Breakthrough Therapy designation to olomorasib plus Keytruda for unresectable advanced or metastatic NSCLC ...
Rising colorectal cancer rates in younger adults are prompting earlier screenings, with colonoscopy offering both detection ...
How can colonoscopy detect colorectal cancer early and prevent it by removing polyps, compared with other noninvasive ...
TAR-200 eliminated tumors in 82% of patients in a phase 2 trial for patients with high-risk non-muscle-invasive bladder ...
Leaving a legacy is essential for many, especially for those who have faced cancer. We long for our friends and family to ...
GLP-1a treatment in patients with polycythemia vera was linked to significant reductions in mortality, disease progression, ...
As we head into Fall, I’ve been thinking about how much this season represents my daughter’s cancer experience for me.
PredicineCARE, a urine-based test, is under FDA review as a companion diagnostic for bladder cancer, building on previous ...
CURE spoke with the author of “Between Two Kingdoms” and “The Book of Alchemy” about the latest chapter in her cancer journey ...
Dr. David A. Taub discussed why Prostate Cancer Awareness Month marks a time to highlight early detection and evolving ...
In observation of Leukemia Awareness Month in September, CURE spoke with an expert about basics of the disease.
The FDA granted two fast track designations to TT125-802, an investigational therapy, for the treatment of ...